November 2021 FDA Recall Drug by Ultratab Laboratories, Inc.
D-0327-2022 - CGMP Deviations

This Class II drug recall was voluntarily initiated by Ultratab Laboratories, Inc. on November 29, 2021 for the product Drug. The FDA reported the reason for recall as cgmp deviations. The product was distributed in Product was distributed to one customer who may have further distributed the product. and the recall is currently terminated.

Recall Number: D-0327-2022

Reason for Recall
CGMP Deviations: failed stability results, inadequate laboratory investigations,
Initiated
11-29-2021
Reported
01-12-2022
Quantity
14 bulk lots (approximately 1,987,951 tablets each)

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
ULTRAtab Laboratories, Inc.
Product was distributed to one customer who may have further distributed the product.
PAIN AID ESF- (Acetaminopehn USP 250mg, Asprin USP 250mg Caffeine 65mg) coated, bulk OTC tablets packaged in corrugated boxes lined with 2 polyethylene bags 100 lb, ULTRAtab Laboratories, Inc. NDC# 62959-560-00, Product Code M560L

Batch or Lot Expiration Information

Lot# Bulk Lots: 18K070, exp. date Nov-21; 19A046, exp. date Jan-22; 19C073, exp. date Mar-22; 19E014, exp. date May-22; 19G039, exp. date Jul-22; 19K002, exp. date Nov-22; 20A013, exp. date Jan-23; 20B050, exp. date Feb-23; 20C011, exp. date Mar-23; 20C049, exp. date Mar-23; 20F071, exp. date Jun-23; 20F072, exp. date Jun-23; 20G033, exp. date Jul-23; 20G041, exp. date Jul-23.